Treatment.com AI News More News
Historical Prices for Treatment.com AI
| Date | Open | Close | Daily High | Daily Low |
|---|
Price change over selected period:
0%
0
Treatment.com AI Analyst Opinions
- All
- Buy
- Hold
- Sell
| Date | Analyst | Rating | Price |
|---|
Income Statements in Mio. CAD
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|
| Sales | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Change of sales in % | - | - | - | - | - | - | - |
| Gross profit on sales | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Gross profit on sales change in % | - | - | - | - | - | - | - |
| Operating income | -2.33 | -3.79 | -13.90 | -2.91 | -0.67 | -0.07 | -0.10 |
| Operating income change in % | 38.56 | 72.75 | -377.84 | -332.54 | -859.37 | 27.39 | - |
| Income before tax | -3.72 | -3.80 | -13.86 | -2.91 | -3.00 | -0.07 | -0.10 |
| Income before tax change in % | 1.96 | 72.61 | -376.72 | 3.19 | -4,186.31 | 27.39 | - |
| Income after tax | -3.72 | -3.80 | -13.86 | -2.91 | -3.00 | -0.07 | -0.10 |
| Income after tax change in % | 1.96 | 72.61 | -376.72 | 3.19 | -4,186.31 | 27.39 | - |
Balance Sheet in Mio. CAD
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|
| Total liabilities | 1.48 | 2.20 | 0.83 | 0.58 | 0.17 | 0.05 | 0.05 |
| Long-term liabilities per share | 0.00 | 0.06 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Equity | -0.74 | -2.19 | 0.12 | -0.26 | 0.35 | 0.01 | -0.04 |
| Equity change in % | 66.28 | -1,894.00 | - | -175.19 | 3,397.62 | - | - |
| Balance sheet total | 0.74 | 0.01 | 0.95 | 0.31 | 0.52 | 0.06 | 0.01 |
| Balance sheet total change in % | 5,306.65 | -98.57 | 204.79 | -39.23 | 711.41 | 476.34 | - |
Key Data in CAD
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|
| Sales per share | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| P/E ratio (year end quote, basic EPS) | - | - | - | - | - | - | - |
| P/E ratio (year end quote, diluted EPS) | - | - | - | - | - | - | - |
| P/E ratio (year end quote) | - | - | - | - | - | - | - |
| Dividend yield in % | 0.00 | 0.00 | 0.00 | - | - | - | - |
| Equity ratio in % | -99.83 | -16,005.58 | 12.78 | -84.05 | 67.93 | 15.76 | -333.48 |
| Debt ratio in % | 199.83 | 16,105.58 | 87.22 | 184.05 | 32.07 | 84.24 | 433.48 |
Treatment.com AI Dividend Calendar
| Date | Name | Dividend | *yield | Currency |
|---|---|---|---|---|
| 2023 | Treatment.com AI Inc Registered Shs | 0.00 | 0.00 | CAD |
| 2022 | Treatment.com AI Inc Registered Shs | 0.00 | 0.00 | CAD |
| 2021 | Treatment.com AI Inc Registered Shs | 0.00 | 0.00 | CAD |
| 2020 | Treatment.com AI Inc Registered Shs | - | - | CAD |
| 2019 | Treatment.com AI Inc Registered Shs | - | - | CAD |
| 2018 | Treatment.com AI Inc Registered Shs | - | - | CAD |
| 2017 | Treatment.com AI Inc Registered Shs | - | - | CAD |
*Yield of the Respective Date
Treatment.com AI Profile
Treatment.com AI, Inc. engages in the research, development, and business development of consumer health services delivered by mobile app technology. It offers the AI transactional platform MERLIN, capable of aggregating, curating and assessing existing and emerging medical knowledge, including primary care, genetics, cancer and heart treatments, and chronic and infectious diseases. The company was founded by John Fraser in 2016 and is headquartered in Bloomington, MN.
Treatment.com AI Shareholder
| Owner | in % |
|---|---|
| Kevin Peterson, MD | 58.04 |
| John Fraser | 15.49 |
| Dong H. Shim, CPA | 12.73 |
| Freefloat | 12.08 |
| Richard Atkins | 1.51 |
Shareholder percentage totals can add to more than 100% because some holders are included in the free float.